GENMAB

Research GENMAB (GE9) with Bullrun company financials, valuation charts, model signals, and historical stock context.

Key Metrics

• TickerGE9
• ExchangeDU
• CountryDenmark
• SectorHealthcare
• IndustryBiotechnology
• CurrencyEUR
• Financial periodFY2025
• RevenueUSD 3.72B
• Revenue growth19.2%
• Net incomeUSD 963.00M
• Free cash flowUSD 1.15B
• Gross margin93.6%